Heartburn medication Zantac recalled due to possible contamination
Residents who own this over-the-counter medication may want to refrain from using it, at least for the time being.
Pharmaceutical company Sanofi announced today that it's recalling heartburn medication Zantac as a precaution "due to potential contamination with a nitrosamine impurity called N-nitrosodimethylamine (NDMA)".
The voluntary recall is in effect in Canada and the US.
The recall comes more than a month after Health Canada and the US Food and Drug Administration reported in September that some ranitidine medicines, including Zantac, could contain NDMA at low levels.
Manufacturers of these medicines have been asked to conduct testing to ensure the safety of the product.
Sanofi has chosen to recall the medication as evaluations continue on both the drug substance (active ingredient) and the finished drug product.
Anyone using Zantac is encouraged to contact their doctor or pharmacist with any questions.
- Premier Doug Ford reveals Brampton is "hot spot" for COVID-19
- Brampton issues 56 additional physical distancing fines amid COVID-19 outbreak
- No mask, no service? Businesses have the right to require masks on customers
- Second employee at Brampton grocery store tests positive for COVID-19
- Police responding to individual in crisis in Brampton
- Chicken Product Recalled Due to Potential Contamination in Brampton
- Popular Flour Product Recalled for Contamination with Harmful Bacteria
- Canadian pharmaceutical company donating drug that could help fight COVID-19
- Bean sprouts product recalled due to possible Salmonella contamination
- Popular Flour Being Recalled for Contamination with Harmful Bacteria